BroadbandOne Expands Fixed Wireless Access into Savannah
BroadbandOne's Licensed mmWave Spectrum offers high speed, multigig, low latency service for enterprise applications, ensuring 99.99% service availability to the region
The
"With FWA-mmWave, all we need is a rooftop and a clear line of sight from our tower—now businesses have access to high-speed, enterprise-grade internet without the wait," said
BB1's licensed spectrum advantage differentiates it from other wireless providers in the region. Unlike unlicensed solutions that may suffer from congestion and interference, BB1's exclusive mmWave spectrum delivers interference-free, high-capacity broadband with a 99.99% uptime guarantee.
Key benefits of BB1's licensed FWA-mmWave service in
- Multigigabit speeds for business-critical applications
- Low latency for seamless cloud services, video conferencing, and data-intensive workloads
- 99.99% availability, backed by real-time monitoring and network redundancy
- Fast deployment, overcoming the challenges of fiber construction delays
BB1's expansion into
"We are committed to delivering a high-capacity, cost-effective broadband solution that complements fiber's strengths," Celaya added. "Markets that need immediate connectivity shouldn't have to wait for fiber buildouts. BB1's solution fills that gap today while supporting long-term fiber growth in parallel."
Beyond
About Broadband One
Broadband One, Inc., doing business as BroadbandOne (BB1), is an innovative wireless network operator and value added partner deploying carrier grade IP connectivity services to enterprises in Tier 2 and 3 and rural markets in the
To learn more about BroadbandOne's wireless network solutions, visit BroadbandOne.com and follow the company on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/broadbandone-expands-fixed-wireless-access-into-savannah-302403978.html
SOURCE BroadbandOne
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Purina and Mariska Hargitay Bring the Purple Leash Project to U.S. Soccer, Launch Limited-Edition Scarves Supporting Abuse Survivors and Pets
- Solana Price Prediction: Samsung Brings USDC to 82M Galaxy Phones, but Pepeto Holders Eye Gains
- First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share